Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Aug;70(4):465-72.

Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors

Affiliations

Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors

A A Maghazachi. Immunology. 1990 Aug.

Abstract

The regulation of rat lymphokine-activated killer (LAK) cell generation from their purified precursors using various cytokines was studied. Several important findings emerged from this study. These include: (i) interleukin-2 (IL-2), but not any other cytokine tested, is pivotal for the development of LAK cells; (ii) transforming growth factor beta 1 (TGF-beta) inhibits IL-2-induced LAK cell differentiation, but not proliferation, regardless of the dose of IL-2 used; (iii) interferon-gamma (IFN-alpha) is inhibitory for LAK cell proliferation, but not differentiation; (iv) tumour necrosis factor-alpha (TNF-alpha) or IFN-gamma synergize with a low but not a high concentration of IL-2; (v) TNF-alpha reverses the anti-differentiative activity of TGF-beta 1 in the presence of a high, but not a low, concentration of IL-2; (vi) anti-p55 IL-2 receptor (R) is not inhibitory for LAK cell development but, on the contrary, a low concentration of this antibody synergizes with IL-2; (vii) IL-1 alpha, IL-1 beta, IL-3, IL-4, IL-6, IFN-alpha. TNF-alpha, or TGF-beta 1 do not affect LAK cell function; and (viii) IL-2 may provide two separate signals for LAK precursors: one is proliferative and the other is differentiative.

PubMed Disclaimer

References

    1. J Immunol. 1988 Jul 15;141(2):690-8 - PubMed
    1. Cancer Immunol Immunother. 1988;26(2):139-44 - PubMed
    1. Cancer Immunol Immunother. 1988;27(1):53-8 - PubMed
    1. Cell Immunol. 1988 Aug;115(1):179-94 - PubMed
    1. J Immunol. 1988 Dec 1;141(11):4039-46 - PubMed

LinkOut - more resources